Swiss Re is proposing a public-private solution in tackling healthcare financing for China's 1.3 billion people
Swiss Re has published a report proposing a public-private partnership approach for the Chinese government's consideration in tackling healthcare financing for China's 1.3 billion people, more than 60% of whom have limited or no access to affordable health protection schemes.
The report, “Reforming Chinese healthcare through public-private partnership”, is the result of a year-long study involving key Chinese policymakers, insurers, regulators and other stakeholders, as well as an investigation into various global systems and best practices. The study was conducted in response to an invitation by the China Insurance Regulatory Commission (CIRC) to undertake an independent review and recommendations of the nation's healthcare system.
Commenting on the report's findings, CIRC assistant chairman Chen Wenhui said, “The Swiss Re study proposes some worthwhile strategies for our review of China's medical insurance system, in particular by highlighting the need for and role of a highly effective commercial health insurance market. Over the past few years, insurance companies have already launched many different commercial health insurance products tailored to the needs of the individual and corporate sectors, contributing constructively to the medical insurance system.”
